discontinue sulfonylurea when starting glp-1 receptor agonist A Closer Look at the Dermatological Profile of Agonists GLP-1 Receptor Agonists: An Alternative

SGLT2 inhibitors are now authorised for the treatment of chronic kidney disease and heart failure in individuals with or without T2DM [1, 2]

Elevations in several biomarkers are indicative of pancreatitis, including serum lipase and amylase that are secreted in bulk by pancreatic acinar cells and thus are the most commonly measured

What We Know So Far About GLP-1 RAs GLP-1 RA head-to-head clinical studies have demonstrated that all GLP-1 RAs are effective at reducing A1C (the average amount of glucose in a persons blood over the past three months)

Supplementary Information Below is the link to the electronic supplementary material

Despite heavy competition from more established companies, Pfizer Chief US Commercial Officer and EVP Aamir Malik said in a Feb

Thirdly, we assessed for heterogeneity of treatment effects across the range of the propensity score by categorising propensity score into tenths based on the distribution among GLP-1 receptor agonist users and including an interaction term between the exposure variable and propensity score tenth in our regression model.37 To assess the robustness of our findings, we did six sensitivity analyses